Clinical Trial Update: Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial) [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating erythropoietin for neonatal encephalopathy in low- and middle-income countries and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Encephalopathy
• Newborn Asphyxia

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Imperial College London | Conditions: Encephalopathy, Erythropoietin | Phase 3 | Status: RECRUITING